Avanir is a most active today up over $1.15 in heavy trading.
Avanir concentrates on chronic diseases that include central nervous system disorders, cardiovascular disorders, inflammation and infectious disease.
The Company's first commercialized product, abreva, is marketed in North America by GlaxoSmithKline Consumer Healthcare and is the leading over-the-counter product for the treatment of cold sores.
Keeping an eye on this stock. They have in clinical trials Neurodex for the treatment of involuntary emotional expression disorder (IEED), is the subject of a New Drug Application under priority review with the FDA. Additionally, Avanir has initiated a Phase III clinical trial with Neurodex as a potential treatment for patients with painful diabetic neuropathy---> diabetics ofter get this. Their feet literally feel like they are on fire. I've read in the literature that the pain is so severe that people have killed themselves or chopped the limb off.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment